ZEVTERA 667 mg/1
ceftobiprole medocaril sodium · INJECTION, POWDER, FOR SOLUTION · La Jolla Pharmaceutical Company
ZEVTERA is a injection, powder, for solution containing ceftobiprole medocaril sodium at 667 mg/1, taken intravenous. Manufactured by La Jolla Pharmaceutical Company.
Key Facts
- Brand Name
- ZEVTERA
- Generic Name
- ceftobiprole medocaril sodium
- NDC Code (Product)
68547-578- Manufacturer
- La Jolla Pharmaceutical Company
- Strength
- 667 mg/1
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA218275
- Marketing Start
- 04/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is ZEVTERA used for?
ZEVTERA contains ceftobiprole medocaril sodium. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.
Is ZEVTERA a controlled substance?
ZEVTERA is not classified as a controlled substance by the DEA.
What is the generic name for ZEVTERA?
The generic name for ZEVTERA is ceftobiprole medocaril sodium. There are no other listed brand versions of ceftobiprole medocaril sodium.
What is the NDC code for ZEVTERA 667 mg/1?
The NDC (National Drug Code) for ZEVTERA 667 mg/1 is 68547-578, listed by La Jolla Pharmaceutical Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)